Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Fluart Innovative Vaccine Ltd, Hungary

Home Clinical Trial Sponsors and OrganizationsFluart Innovative Vaccine Ltd, Hungary

Fluart Innovative Vaccine Ltd, Hungary

ACTIVE

Private

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

11

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Not Applicable

6

54.5%

Phase 4

3

27.3%

Phase 1

1

9.1%

Phase 3

1

9.1%

Trial Status Distribution

Completed

11

100.0%

Clinical Trials

Trials sponsored by this organization (11)

Safety of 4Fluart ID Suspension for Injection in Adult Subjects

Jan 201836 participants

Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents

Oct 2014120 participants

Tolerability and Immunogenicity Study of Fluval AB Suspension for Injection

Aug 2013120 participants

Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination Season

Aug 2012120 participants

A Study to Evaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly Subjects

Oct 20111,206 participants

Safety and Immunogenicity Study of Fluval AB-Like Flu Vaccines With 3.5, 6, 9 or 15 μg HA in Adult and Elderly People

Sep 2011256 participants

Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons

Jul 2011121 participants

Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in Children

Sep 200910 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials11
Approvals
News

Back to Organizations